Hologic earnings beat by $0.03, revenue topped estimates

Investing.com – Hologic (NASDAQ: ) reported first quarter EPS of $0.98, $0.03 better than the analyst estimate of $0.95. Revenue for the quarter came in at $1.01B versus the consensus estimate of $986.95M.

Guidance

Hologic sees Q2 2024 EPS of $0.95-$1.00 versus the analyst consensus of $0.98.

Hologic sees Q2 2024 revenue of $990.00M-$1.01B versus the analyst consensus of $990.00M.

Hologic sees FY 2024 EPS of $3.97-$4.12 versus the analyst consensus of $4.00.

Hologic sees FY 2024 revenue of $3.99B-$4.06B versus the analyst consensus of $3.99B.

Hologic’s stock price closed at $74.41. It is up 8.36% in the last 3 months and down -11.88% in the last 12 months.

Hologic saw 4 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See Hologic’s stock price’s past reactions to earnings here.

According to InvestingPro, Hologic’s Financial Health score is “great performance”.

Check out Hologic’s , and Hologic’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar